glp 1 agonist review article Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping GLP-1 Receptor Agonists: Effects on

They found that polymorphisms in the DPP4 gene increase the risk of MI and progression of atherosclerosis in terms of plaque stability in patients with already existing CAD

What to know Obesity is a known risk factor for breast cancer, so could some women reduce their odds of this common type of cancer by taking weight-loss drugs such as Wegovy and Zepbound

Am J Physiol 273(4):G920G927

The clinical significance of this slight difference is debatable, but the effect is mentioned here as a possible off-target effect of DPP-4 inhibitors

At The Care Pharmacy, our UK pharmacists provide clear guidance, safe treatment pathways, and personalised support for people considering GLP-1 options

In the last three months of 2023, more than 9 million people were treated by GLP-1 analogues in the US, with anticipation of continued rapid growth in usage